BX
Baudax Bio, Inc.
BXRXQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.36K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.00x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 4,476.99%
Gross margin 452.33%
FCF margin 2,191.73%
Quality
59 /100
Average Asset turnover 0.13x
ROIC 974.83%
ROA 586.08%
Debt
70 /100
Low Net debt/EBITDA -0.06x
Current ratio 0.30x
Debt/Assets N/A
Stability
14 /100
Unstable Profitable years 0
Beta 9.17x
EPS volatility 55.97%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BXRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerri Henwood
Employees
9
Headquarters
Malvern
Nadcházející události
11 LIS
Earnings
Upcoming earnings report